共 567 条
[1]
Nebert DW(2006)Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomics Trends Pharmacol Sci 27 580-586
[2]
Vesell ES(2005)Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy Philos Trans R Soc Lond B Biol Sci 360 1563-1570
[3]
Ingelman-Sundberg M(2007)The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects Am Fam Physician 76 391-396
[4]
Rodriguez-Antona C(2004)Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response Mol Psychiatry 9 442-473
[5]
Lynch T(1994)Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians J Pharmacol Exp Ther 270 414-423
[6]
Price A(2002)Common allelic variants of cytochrome P4503A4 and their prevalence in different populations Pharmacogenetics 12 121-132
[7]
Kirchheiner J(2007)Individualized drug therapy Curr Opin Drug Discov Dev 10 29-36
[8]
Nickchen K(2000)CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity Clin Pharmacol Ther 67 48-56
[9]
Bauer M(2005)CYP3A4 and CYP3A5 genotyping by Pyrosequencing BMC Med Genet 6 19-1069
[10]
Wong ML(2004)CYP3A variation and the evolution of salt-sensitivity variants Am J Hum Genet 75 1059-391